Delivery Order SPE2DB22D3501-SPE2DB24FUH69
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. The $5,422.27 order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,441.64 order is for the provision of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp, the prime contractor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The total ceiling value of this order is $5,336.35 and the period of performance runs through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $3,771.11, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to reverse opioid overdose. The order has a performance period through March 27, 2024 and does not use any set-aside designation. Amerisourcebergen Drug Corp is the prime...
- The Defense Logistics Agency (DLA) awarded a $1,799.60 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. This $1,349.70 award has a completion date of February 7, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- This is a $2,530.77 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. The contract has a performance period through July 7, 2025 and is not set aside. Amerisourcebergen also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, allowing the company to supply a wide range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $1,556.56, has an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- This delivery order, valued at $19,155.41, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply NARCAN 4 MG NASAL SPRAY 2S. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a period of performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The $4,028.32 firm fixed-price contract has a completion date of February 2, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUH69Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,524.39 order is for NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The order is placed under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The order has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/25/24 |